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A 2 point procedure for the enzymatic determination of glucose concentrations, using hcxokinase and glucosc-6-phosphate dehydrogenase,
was evaluated with a GEMSAEC analyzer. The proposed method appears to be very useful in clinical chemistry for several reasons: it
has a high reliability and docs not need a deproteinisation step; with the exception of glucose-6-phosphate, no other substance has been
found so far that causes significant interference; a single analysis takes 7.5 minutes; drift and interaction effects can be neglected.
Capillary blood, serum, cerebrospinal fluid or urine can be analyzed without the determination of a sample blank value. Blood is collected
with 40 μ\ glass capillaries, then transferred into a sodium chloride solution containing maleimide to avoid glycolysis. Under these con-
ditions blood samples can be transported by a pneumatic tube system and stored for several days.
Ein Zweipunkt-Me verfahren wurde zur enzyrhatischen Bestimmung der Glucosekonzentration mit Hexokinase und Glucose-6-phos-
phatdehydrogenase an einem GEMSAEC Analysenautomaten entwickelt und auf seine Zuverl ssigkeit untersucht. Die vorgeschlagene
Methode ist aus mehreren Gr nden f r die Klinische Chemie besonders geeignet: sie hat eine gro e Zuverl ssigkeit und ben tigt keinen
Enteiwei ungsschritt; bisher wurden mit Ausnahme von Glucose-6-phosphat keine signifikanten Interferenzen gefunden; das Ergebnis
einer Einzelbestimmung liegt nach 7,5 Minuten vor; Drift- und Verschleppungseffekte k nnen vernachl ssigt werden.
Kapillarblut, Serum, Liquor oder Urin k nnen ohne Mitf hren eines Probenleerwertes analysiert werden. Blutproben werden mit 40 μ\
Glaskapillaren dosiert und in Vorlagen mit einer L sung von Natriumchlorid und Maleimid zur Glycolysehemmung ausgesch ttelt.
Unter diesen Bedingungen k nnen die Proben per Rohrpost transportiert und einige Tage aufbewahrt werden.
The enzymatic determination of the glucose concen- Solutions
tration with hexokinase and glucose-6-phosphate de- ι. Sodium chloride solution: 9 g Nad (Merck No. 6404), 200 mg
hydrogenase (Hexokinase method) is now widely used maleimide (Schuchardt Nr. MA 084) + bidist. H2O to 1000 ml.
for clinical purposes. Automatic procedures mostly This solution was stable for at least 4 weeks at room temperature,
require the separation of serum proteins before the 2. Glucose standard, 10mmol/l: 450.4mg dried glucose (Merck
reaction can be started (1, 2), or the determination of a No· 8337>> 250mS sodium azide (Merck No· 6688> + bidist-
τ , τ , τ »ru- j· j · · i_ H2Oto250ml.sample blank value. This disadvantage is overcome with
analyzers which are able to take at least 2 readings 3. Glucose xvorking standard: 4.0ml solution (2) + 50.01 ml
. / . solution (1). This solution was stable for at least 1 month at 4°C
during the reaction (14).
 and was added directly to the Rotoloader cups.
A GEMSAEC analyzer (3-6) was used to evaluate
 4 Potassium dichromate (Merck No. 4864), was dissolved in
such a two-point method for the determination of the
 0.01 mol/1 H2SO4 (Merck No. 9982) to give an absorbance of
glucose concentration based on a commercially available approx. 0.455 at 340 nm (4.5 mg/1).
test combination. 5. Reaction mixture: Solutions 1—4 were taken from the Bio-
Blood samples were taken from finger tips with hep- chemica test combination; the volume of solution 2—4 were
arinked glass capillaries as recently described (2, 7) and chosen to °P*mize the concentration of enzymes and cofactors
r i · j- ι ι · j Λ /ce\r\ i\ (Fig- la—c)· The concentrations of the enzyme suspension were
transferred into sodium chloride solution (500^1)
 noraltered because these investigations ought to be based on the
containing maleimide to avoid glycolysis (8). commercially available test combination. The slight downward
deflection of the saturation curve in Figure Ic at higher enzyme
Materials concentrations was probably caused by the concomitant increase
. of NH4 ions.
The solutions of the reaction mixture were taken from the Bio-
 End concentration of assay:
chemica test combination No. 15931 of C. F. Boehrmger GmbH _ . .
 Λ 0. . _ . . , „_ ... ... 0 _tr\ so XT ι. · \ u iu · /j · j \ j · · Solution 1 89 ml Trietnanolamme 205 mmol/l, MgSO4(D-68 Mannheim); bovine albumin (dried, purest) and precision - _ . ... u __
 7 ς
control sera were purchased from Behringwerke AG (D-355 Mar-
 c , . „ . . ί/Λ^Τ^ P m
u \ ι * Λ- i_ * ^ T - S i _ · Λ t _ T T /ντ Solution 2 5ml NADP 0.46 mmol/lburg), glucose-6-phosphate from C. F. Boehrmger GmbH (No.
 0 . . - _ . A ^ r » n x o 1/1ieirw\ i - -j r τ-. TU. οι . u j /τ> o x>r · ι_\ AT · Solution 3 5ml ATP 0.62 mmo 1/115307), maleimide from Dr. Th. Schuchard (D-8 Munich). Mom-
 0 . . . „ . T1 . . _ ' ,.
trol from Me« and Dade (D-8 Munich), all other chemicals p. a. f°lutl°n 4 1 m Hexokrnase 7.69 mg/1
from E. Merck AG (D-61 Darmstadt), reaction cups (No. 39/10) ^^me Wns.on) Gbcosc-6-phosphat-dehydrogenasc
with their corresponding caps (No. 98) and heparinized mono- ' *' '
vettes (No. 750) from W. Sarstedt (D-5223 Numbrecht), and This reaction mixture was stable at least 24 h at 4°C or 7 h at room
heparinized glass capillaries from W. Vogel (D-63 Gie en). temperature.
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The optimal concentrations of
cofactors and enzymes. The re-
action mixture is the same as
described under methods, except
for ATP in Fig. la, NADP in
Fig. 1 b and the enzyme suspen-
sion in Fig. 1 c of which various
concentrations are used as in-
dicated. Substrate: 20 mmol/1
glucose. Each point is a mean of
3 determinations
Instrumentat ion
Electro Nucleonics Inc. (USA, Fairfield 07006): GEMSAEC
analyzer with control module (Serial No. 2113) and Rotoloader
(Serial No. 008) with Micromedic dispensers (Serial No. 557 for
sample + diluent, and serial No. 609 for reagent). Eppendorf
Ger tebau GmbH (D-2 Hamburg): Microcentrifuge 3200, micro-
pipettes, dispenser 5231.
Methods ·, \
Blood samples (40 μϊ) were taken with heparinized glass capillaries
after skin puncture. The filled capillaries were introduced into an
Eppendorf reaction cup with 500 μ\ saline solution which con-
tained maleimide to delay glycolysis (Tab. 1). After the cup was
closed and shaken it could be either stored at 4°C or transported
by a pneumatic tube system. The reaction cups were filled up to
4 weeks prior to use. During this time the fluid loss did not
exceed 1% if the cups were carefully closed and stored at room
temperature.
Tab. 1
The stability of the glucose concentration (mmol/1) in 40 μ\ blood samples
taken up in 500 μ\ sodium chloride (9 g/1). Blood was aspirated in
monovettes containing heparinized beads, distributed into various
reaction cups filled with NaCl solution and stored as indicated below.
Each value is a mean of 2 determinations.
Storage, days 0 1 2 3 4
NaCl + Maleimide
(200 mg/1) stored at 4°C
NaCl + Maleimide
(200 mg/1) stored at 20°C
NaCl stored at 4°C
NaCl stored at 20eC
4.7
4.7
4.6
4.6
4.7
4.7
3.4
2.9
4.7
4.8
2.5
2.0
4.7
4.8
1.8
1.2
4.7
4.8
1.2
0.6
Tab. 2
Summary of the methodology of the glucose determination with the
GEMSAEC analyzer
Blood volume 40 μϊ
Sodium chloride/Maleimide 500 μ\
Glass capillary
Eppendorf dispenser
Centrifugation for l min
Supernatant
Diluent (bidist. H2O)
Reaction mixture
GEMSAEC set up:
1. Reading
2. Reading
50 ul
100 μϊ
500 μ\
7s
99s
Rotoloader
Rotoloader
Rotoloader
after start
after start
Temperature: 25°C
Wavelength: 340 nm
Filter: 335—385 nm
Header tape: Increasing rate reaction with ratiornetric calculation
Prior to the analysis, the reaction cup was centrifuged for l min
in an Eppendorf microcentrifuge without removing the glass
capillary. The supernatant could either be transferred to a Roto-
loader or directly to a cuvette-rotor using a 50 μΐ Eppendorf
pipette.
The protocol for the Rotoloader and the GEMSAEC analyzer
are summarized in Table 2. If 20 μ\ glass capillaries are used, the
sample volume must be increased to 100 μϊ. The analyzer auto-
matically takes 8 readings (during approx. 1 second) for the first
and for the second point. The difference of both mean values is
printed out together with the final result (in mmol/1).
Sequence of samples
Cuvette 1 : standard
Cuvette 2 : control serum
Cuvette 3—15 : unknown samples
Cuvette 16 : control serum or unknown sample.
The recovery of glucose added to various serum samples was
calculated from the results of the following assays:
1. 9.0ml bidist. H2O + 1.0ml glucose solution (100 mmol/1);
2. 9.0ml pooled serum + 1-0 glucose solution (100 mmol/1);
3. 9.0 ml pooled serum + 1.0 mi bidist. H2O.
The interaction from low to high concentrations (Qj) and from
high to low concentrations (Q2) was determined as recently re-
ported (10) and expressed as the percent interaction coefficient:
Q = 100 X q. (For the explanation of q see 9, 10, 11).
The detection limit was determined by using bidist. H2O as a
sample during 20 runs with the two-point procedure: the three-
fold standard deviation of the mean value is a measure for the
detection limit according to KAISER (12).
Statistical analysis
For the determination of the precision 2 identical serum samples
(xa, Xb) are serially analyzed. The precision-within-series
100 · x)(CVS = is calculated from the xa and xt> values:
Xbl)
,. 2m
The precision-from-day-to-day is calculated from the x*r (or the
Xb-) values:
(2)Xa =
n — l
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Results
Preparation of samples
During these investigations disposable 40 μΐ gkss
capillaries were used for blood sampling. Their pre-
cision was tested by weighing bidist. H20:39.76 ±
0.26 μ\ (η = 32). The coefficient of variation was
0.6% (room temperature was taken into account).
Recently it was reported that even 20 μ\ capillaries can
be used with sufficient precision for clinical purposes
(2, 7).
Precision
The overall precision of the optical and the read-out
system was determined by dichromate solutions of
varying concentrations (Fig. 2). The data obtained
agreed well with those reported by MACLIN (13). The
precision of the Rotoloader and the overall [precision of
the glucose determination are summarized in Table 3
and 4. The precision from-day-to-day (Tab. 4b) was
0.0015
10.001
c 0.0005
•f 0.0004
jj 0.0003
I 0.0002
0.0001 0,5 10 1.5 2.0
Fig. 2
The overall. precision of the optical and the read-out system of the
GEMSAEC arialyzer. The rotor was filled with 500 μ\ samples of
dichromate solution of varying concentrations. Wavelength: 340 nm;
1. reading: 5 s; reading interval: 2 s; number of readings: 26.
Tab. 3
Precision of the Rotoloader
Station
Sample
Diluent
Reagent
Volume
setting
50
50-f 100
500
x(/*l)
50.06
134.30
500.00
η
(16)
(20)
(20)
CV(%)
0.43
0.85
0.12
Tab. 4a
Precision within-series of the glucose determination with the
GEMSAEC analyzer
Sample χ s
(mmol/1) (mmol/1)
η CV*
I. Standard solution 0.49
1.08
1.93
5.95
9.17
18.78
0.03
0.03
0.05
0.09
0.11
0.12
(14)
(14)
(14)
(14)
(14)
(14)
5.5
3.0
2.5
1.5
1.2
0.6
II. Asid control serum
(Charge No. 402 C)
6.04 0.07 (17) 1.2
Tab. 4b
The precision from-day-to-day of the glucose determination with the
GEMSAEC analyzer. Asid control serum (Charge No. 402 C) was
analyzed on various days and referred to either 1 standard or to the
mean value from several standards
Number of standards 1
Mean value (mmol/1)
Standard deviation (mmol/1)
Coefficient of variation (%)
Number of observations
6.01 5.97 5.97 5.95 5.98
0.14 0.15 0.15 0.15 0.16
2.3 2.5 2.5 2.5 2.6
17 17 17 17 17
not significantly improved if the results were referred
to the mean of several standards instead to one standard
value.
In most cases, analyzer runs are started only once a
day after a series has been completed. These series
usually consist of several segments (11). When a
sequence of for instance 100 samples has to be analyzed
with a GEMSAEC, it is a matter of definition to con-
sider each run a series per se or just a segment of the
whole series. For the purpose of comparing precision
data from various analytic systems, it is suggested that
each run be regarded as a series per se. Three types of
precision can then be expected: 1. the precision within-
series, 2. the precision between-series (during 1 day)
and 3. the precision from-day-to-day.
The precision between-series (interbatch precision)
must be differentiated from the precision from-day-to-
day as shown in Table 5: 10 suceeding runs of the same
control serum were analyzed for 8 days. The coefficient
of variation (CV) was calculated for each run: XGV =
2.1%. The precision between-series can be estimated
from the first (or any other) value of each run during
a day. The mean value of 8 days was 3.4%. In the same
way, the precision from-day-to-day can be calculated
from the first (or any other) value of the first (or any
other) run during the 8 days (Tab. 5).
Tab. 5
The 3 types of precision observed with a GEMSAEC analyzer using
Behring control serum (Lot. No. 112). Each run yielded 12 values
which were referred to 1 standard value (10 mmol/1), and was daily
repeated ten times for 8 days. The mean value of all determinations
was 5.2 mmol/1 (n =960)
Type of precision Coefficient of variation*)
1. Precision within-series
II. Precision between-series
II. Precision from-day-to-day
2.1 (n= 80)
3.4 (n = 96)
4.9 (n = 120)
*) Coefficient of variation
*) mean value of η calculations
The detection limit determined according to KAISER
(12) was 0.13 mmol/1; the range of extreme values was
0.000—0.002 absorbance units.
Accuracy
The 2-point procedure of the hexokinase method
appeared to be linear between 0 and 20 mmol/1 (Fig. 3).
This range covers 99% of the routine and about 95%
of all emergency glucose determinations performed in
our hospital.
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Fig. 3
Calibration curve of the two-point procedure for the determination
of the glucose concentration with the GEMSAEC analyzer
Glucose was added to various serum samples. The
recovery varied from 100.0% to 100.7% (Tab. 6).
Furthermore, we measured the glucose concentration
in capillary blood with the 2-point- and with an end-
point method. The latter included a deproteinisation
step and was recently investigated in detail by us (2).
The correlation between both procedures was sufficient
for clinical purposes (Fig. 4).
Interferences
Recently, we have reported (2) that the glucose values
are slightly higher as expected in the presence of fructose
using the hexokinase method and the endpoint deter-
t5
<t
α>
a
— 3
<! 2
I I \ \ I
Ο Γ '2 3 4 5 6 7 8 9
Glucose (Gemsaec Analyzer) [mmol/l]
Fig. 4
Comparison of the glucose determination with the GEMSAEC (Two-
point method) and with the Eppendorf analyzer (endpoint procedure)
in capillary blood samples. Coefficient of correlation r == 0.9957;
y = 0.9957 x—0.0184 (m = 177)
mination. This interference is avoided with the 2-point
procedure (Tab. 6). Bilirubin, hemoglobin (up to
8 g/1) and triglycerides (up to 5 mmol/l) do not influence
the results obtained with the proposed method (Tab. 6).
The only interference so far known is caused by glu-
cose-6-phosphate, if present in concentrations above
0.2 mmol/l.
Interaction
Recently we have differentiated between cyclic- and
from-sample-to-sample interaction effects (11).
Interaction from-sample-to-sample was not detected
Tab. 6
Recovery of glucose added to various human serum samples and to aqueous solutions containing possible interfering substances. All values are
means from at least 2 determinations
Sample
Serum 1
Serum 2
Serum 3
Serum 4
Serum 5
Glucose solution -f fructose
Fructose solution
Haemoglobin solution
Glucose solution -f haemoglobin
Glucose solution -f haemoglobin
Serum 6 + bilirubin
Serum 7 -f- bilirubin
Serum 8 (lipemic)
Serum 9 (lipemic)
"Blood, heparinized + fructose
Blood, heparinized + fructose
Glucose-6-phosphate solution
Glucose-6-phosphate solution
Glucose calculated
(1 + 3)*)
mmol/l
15.1
13.0
13.1
15.8
15.0
10.4
<0.1
<0.1
10.5
10.3
11.7
10.5
17.2
14.3
4.0 '
4.1
0.1
0.1
Glucose found
(2)*)
mmol/l
15.2
13.0
13.1
15.9
15.1
10.4
<0.1
<0.1
10.5
10.2
11.6
10.4
17.3
14.2
4.0
4.1
4.6
0.4
Recovery
%
100.7
100.0
100.0
100.6
100.7
100.0
—Α-
Ι 00.0
99.0
99.1
99.0
100.6
99.3
100.0
100.0
—
—
Concentration of
interfering substance
—
—
—
-u
20 mmol/l
20 mmol/l
8.6 g/i
8.6 g/l
4.3 g/1
306 pmol/l
306 /miol/l
4.20 mmol/l**)
4.78 mmol/l**)
9.5 mmol/l
9.5 mmol/l
6.4 mmol/l***)
0.6 mmol/l***)
*) see under methods (recovery experiments)
***) determined enzymatically according to (15)
**) triglyceride concentration (determined enzymatically)
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Fig. 5
The "interaction-safe range" (10, 11) of the glucose determination
with the GEMSAEC system. The concentrations forming this range
are calculated according to (10): ci,i for the interaction from low to
high concentrations and C2,i for the interaction from high to low
concentrations. The standard deviations are taken from Table 4.Q = 0.3% (n = 5). It is postulated that the error due to carry-over
effects should be lower than the twofold (hatched area) or the threefold
value of the intrabatch precision (standard deviation)
in the linear range of the 2-point procedure, from low
to high, or from high to low concentrations. However,
if a sample with 100 mmol/l is followed by 3 samples
with 2 mmol/l glucose, a mean Q2 value of 0.3%
(s = 0.1, n = 5) was determined. This slight inter-
action effect will cause serious errors only under ex-
treme conditions: as a rule of thumb, we suggest that
all samples be reanalyzed with a glucose concentration
below 2 mmol/l if the preceeding concentration exceeds
50 mmol/l (Fig. 5). This type of interaction occurs only
at the Rotoloader station. If the rotor is loaded manually,
carry over effects are not to be expected.
Cyclic interaction effects are encountered if the washing
step is unsufficient. 2 successive runs were performed
with the same rotor using various albumin solutions
(Tab. 7). No significant cyclic interaction was detected
with the biuret reaction.
Drift
A possible drift of the photometer and print-out
system was investigated with a potassium dichromate
solution (A A = 0.455 at 340 nm): The absorbance was
observed for 30 min and drifted about A = 0.00003/
Tab. 7
Investigation of cyclic interaction effects. Sample: albumin solution.
Indicator: biuret reaction
Cuvette number Albumin concentration Print-out
1. Run No. 2—7
8—16
2. Run No. 2—7
8—16
20 g/l X =20.35 (s »0.25)
250 g/l out of linear ränge
20 g/l X =20.00 (s =0.13)*)
20 g/I 32 «20.10 (s =0.10)*)
*) This difference is not significant: P =0.06 (t-test)
min (n = 15). These data indicate that drift effects can
be neglected if the observation is not extended over
a period of 30 min.
Time of analysis
For the 2-point procedure of the hexokinase-method
each run needs its own standards and at least 1 control.
Therefore, a minimal sequence contains 3 samples,
which can be analyzed in 7.0 min excluding the blood
sampling time (Tab. 8). The rotor loading requires
the longest part of the total time.
Tab. 8
Time per test required for determinations of the glucose concentration
with the GEMSAEC analyzer
Number of unknown samples
(including 1 standard and
1 control)
1 12
Sampling time, seconds 30 13x30
1. Centrifugation (1 min)
2. Rotor loading
3. Analyzer run
4. Overall time
5. Time per test
1 min 30 s
I min 50 s
3 min
7 min
7.0 min
1 min 30 s
4 min 45 s
3 min 15 s
11 min
0.8 min
12
§10
o
:
g 6
U)
J_ l J_
2 4 6 8 10
Glucose (Eppendorf Analyzer 5030) [mmol/ l l
12
Flg. 6
Comparison of glucose values determined with the 2-point procedure(GEMSAEC) and with an endpoint procedure (Eppendorf analyzer5030:
see 1. c. 2) of the hexoklnase method in urine and cerebrospinal fluid(crosses) samples. Regression analysis: y « 1.0207 —0.10915,
r - 0.9993 (m - 69 pairs of data)
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Very soon, a faster loader will be introduced by the
manufacturer of the GEMSAEC system. For suc-
ceeding runs a second rotor can be filled while the first
is· positioned in the analyzer. This procedure saves
approx. 3 min for the next run. Therefore about 91
samples can be processed in the first hour and thereafter
97 samples per hour.
Urine samples
Urine and cerebrospinal fluid samples were diluted
with NaCl (9 g/1) containing maleimide and analyzed
for their glucose concentration in the same way as
capillary blood. The comparison with an endpoint
procedure of the hexokinase method (2), which in-
cludes the precipitation of proteins and the determina-
tion of a blank value for urine samples, shows an
acceptable correlation (Fig. 6).
Discussion
The GEMSAEC analyzer permits a 2-point procedure
of the hexokinase method which is precise enough for
the determination of glucose concentrations for clinical
purposes. This method has 3 distinct advantages over a
mechanized endpoint procedure recently described by
us (2):
1. it is subject to less interference (Tab. 6), despite the
fact that deproteinisation is not carried out,
2. single samples are processed more rapidly (Tab. 8),
and
3. urine can be analyzed without performing a sample
blank value.
A further advantage of the GEMSAEC system is that
carry-over effects can almost be neglected. Whereas the
analyzer itself does not contribute to the over-all inter-
action from sample to sample, the Rotoloader causes
such an effect. However, the prerinsing device and the
cleaning of the sample-pick-up tip with a small sponge
keeps the sample carry-over extremely low. Determina-
tions, which require a high precision and meet a
relatively large range of extreme values, e. g. the
glucose concentration in human material, should be
performed with low interaction effects (10, 11).
The over-all kinetics of the hexokinase and glucose-6-
phosphate dehydrogenase reaction follow an exponential
curve and will be discussed in a following report.
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